Gaush Meditech Expects to Post Lower H1 Profit; Shares Plummet 7%

MT Newswires Live
07/24

Gaush Meditech (HKG:2407) expects to report a net profit of 13.9 million yuan to 16.7 million yuan for the first half of 2026, down 53.5% to 61.3% from 35.9 million yuan a year earlier.

The company attributed the expected decline to lower revenue amid shifts in market demand driven by national policies, the termination of its agency partnership for overseas femtosecond laser-assisted cataract surgery products, and exchange rate fluctuations, according to a Thursday Hong Kong bourse filing.

Shares of the company fell over 7% in recent trade.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10